This versatile compound is now actively investigated for its potential to combat age-related diseases, neurodegeneration, and to support human longevity 1 -4
If you're dealing with persistent symptoms and want personalized guidance, Doctronic offers AI-powered consultations that can help you understand your symptoms and determine next steps
Overman MJ, Yothers G, Puhalla SL, Sanoff HK, Cohen DJ, Guthrie KA, Ganz PA, Kopetz S , Lucas PC, Blanke CD, Jacobs SA, Hong TS, Wolmark N, Hochster HS, George TJ, Lima CM
Cells 11 , 2465 (2022)
One injection every three months is not sufficient for people with pernicious anemia
While initial Phase 2 data demonstrated distinct metabolic effects from this concurrent activation [3], Retatrutide has since advanced into Phase 3 clinical evaluations including the TRIUMPH clinical program to further characterize its triple-agonist profile